News details

Oct 29, 2020

These past few months, changes have taken place due to the Covid-19 pandemic and our society has adapted accordingly.

With working days and children at school, it is important to be cautious with respiratory tract infections. They are still around and it’s for this reason that we must stay vigilant to limit the spread of infections. It’s more important than ever to prevent infection and stimulate our immune defenses.

It is in that frame, that Lallemand Pharma worked hardly to find ways to improve the partners, doctors and patients experience, through development of clinical research programs, supports for its partners and improvement of  the quality of PMBL sublingual tablets.

You can subscribe to our newsletter here : Newsletter Subscription